ES2086090T3 - Derivados de 4-pirimidinas, su preparacion y su aplicacion en terapeutica. - Google Patents

Derivados de 4-pirimidinas, su preparacion y su aplicacion en terapeutica.

Info

Publication number
ES2086090T3
ES2086090T3 ES92400269T ES92400269T ES2086090T3 ES 2086090 T3 ES2086090 T3 ES 2086090T3 ES 92400269 T ES92400269 T ES 92400269T ES 92400269 T ES92400269 T ES 92400269T ES 2086090 T3 ES2086090 T3 ES 2086090T3
Authority
ES
Spain
Prior art keywords
sub
rent
eventually substituted
nucleus
straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92400269T
Other languages
English (en)
Inventor
Christian Hoornaert
Marc Daumas
Michel Aletru
Jean-Claude Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Application granted granted Critical
Publication of ES2086090T3 publication Critical patent/ES2086090T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

1. COMPUESTOS, QUE EXISTEN BAJO TRES FORMAS TAUTOMERAS, QUE RESPONDEN A LAS FORMULAS GENERALES (I), (I'') Y (I'''') EN LAS QUE R SUB 1 = (C SUB 1-7)ALQUILO RECTO O RAMIFICADO, (C SUB 3-9)ALCENILO RECTO O RAMIFICADO, CICLO(C SUB 3-7)ALQUIL(C SUB 1-6)ALQUILO, R SUB 2 = H, (C SUB 1-7)ALQUILO RECTO O RAMIFICADO, CICLO(C SUB 3-7)ALQUIL(C SUB 1-3)ALQUILO, ARILO(C SUB 1-3)ALQUILO EVENTUALMENTE SUSTITUIDO EN EL NUCLEO, ARILOXI(C SUB 1-3)ALQUILO EVENTUALMENTE SUSTITUIDO EN EL NUCLEO, ARILTIO(C SUB 1-3)ALQUILO EVENTUALMENTE SUSTITUIDO EN EL NUCLEO, ARILSULFONIL(C SUB 1-3)ALQUILO EVENTUALMENTE SUSTITUIDO EN EL NUCLEO, HETEROARIL(C SUB 1-3)ALQUILO EVENTUALMENTE SUSTITUIDO EN EL NUCLEO, R SUB 3 = CO SUB 2H, 1H-TETRAZOL-5-ILO, NHCOR SUB 11, NHSO SUB 2R SUB 11, CONHSO SUB 2R SUB 11, CONHOR SUB 12, DONDE R SUB 11 = CH SUB 3, CF SUB 3, O FENILO EVENTUALMENTE SUSTITUIDO, R SUB 12 = H, CH SUB 3 O FENILO EVENTUALMENTE SUSTITUIDO, ASI COMO SUS SALES ORGANICAS O INORGANICAS FARMACEUTICAMENTE ACEPTABLES. APLICACIONTERAPEUTICA.
ES92400269T 1991-02-20 1992-02-03 Derivados de 4-pirimidinas, su preparacion y su aplicacion en terapeutica. Expired - Lifetime ES2086090T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9102032A FR2672892B1 (fr) 1991-02-20 1991-02-20 Derives de 4-pyrimidinones, leur preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
ES2086090T3 true ES2086090T3 (es) 1996-06-16

Family

ID=9409925

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92400269T Expired - Lifetime ES2086090T3 (es) 1991-02-20 1992-02-03 Derivados de 4-pirimidinas, su preparacion y su aplicacion en terapeutica.

Country Status (23)

Country Link
EP (1) EP0500409B1 (es)
JP (1) JP2529798B2 (es)
KR (1) KR920016434A (es)
CN (1) CN1034171C (es)
AT (1) ATE135695T1 (es)
AU (1) AU650319B2 (es)
CA (1) CA2061456A1 (es)
CS (1) CS49092A3 (es)
DE (1) DE69209113T2 (es)
DK (1) DK0500409T3 (es)
ES (1) ES2086090T3 (es)
FI (1) FI920720A7 (es)
FR (1) FR2672892B1 (es)
GR (1) GR3019404T3 (es)
HU (2) HUT60477A (es)
IE (1) IE76145B1 (es)
IL (1) IL101014A (es)
MX (1) MX9200690A (es)
NO (1) NO920648L (es)
NZ (1) NZ241659A (es)
PL (1) PL168617B1 (es)
RU (1) RU2073675C1 (es)
ZA (1) ZA921203B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd Biphenyl substituted heterocyclic compounds their production and pharmaceutical compositions comprising them
FR2700543B1 (fr) * 1993-01-15 1995-03-17 Synthelabo Sels de dérivés de 4-pyrimidinone, leur préparation et leur application en thérapeutique.
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2627848T3 (es) 2008-06-04 2017-07-31 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
ES2433225T3 (es) * 2009-01-30 2013-12-10 Takeda Pharmaceutical Company Limited Compuesto con anillos condensados y uso del mismo
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
PL3004138T3 (pl) 2013-06-05 2024-07-29 Bausch Health Ireland Limited Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US5064825A (en) * 1989-06-01 1991-11-12 Merck & Co., Inc. Angiotensin ii antagonists
KR0163595B1 (ko) * 1989-06-30 1998-12-01 미리암디, 메코너헤이 치환된 이미다졸
EP0407342A3 (en) * 1989-07-06 1991-07-10 Ciba-Geigy Ag Pyrimidine derivatives
EP0424317A3 (en) * 1989-10-19 1991-09-25 Ciba-Geigy Ag Pyrimidines
EP0435827A3 (en) * 1989-12-28 1991-11-13 Ciba-Geigy Ag Diaza compounds
WO1991015209A1 (en) * 1990-03-30 1991-10-17 Merck & Co., Inc. Substituted pyrimidines, pyrimidinones and pyridopyrimidines
IE912114A1 (en) * 1990-07-02 1992-01-15 Union Pharma Scient Appl Novel pyrimidine derivatives which are angiotensin ii¹receptor antagonists, their methods of preparation and¹pharmaceutical compositions in which they are present

Also Published As

Publication number Publication date
HU9200532D0 (en) 1992-05-28
DK0500409T3 (da) 1996-07-15
KR920016434A (ko) 1992-09-24
JP2529798B2 (ja) 1996-09-04
CA2061456A1 (en) 1992-08-21
IE920525A1 (en) 1992-08-26
EP0500409B1 (fr) 1996-03-20
NO920648D0 (no) 1992-02-19
CN1064269A (zh) 1992-09-09
MX9200690A (es) 1992-08-01
DE69209113T2 (de) 1996-10-31
PL168617B1 (pl) 1996-03-29
IL101014A (en) 1996-06-18
IE76145B1 (en) 1997-10-08
FR2672892A1 (fr) 1992-08-21
RU2073675C1 (ru) 1997-02-20
ATE135695T1 (de) 1996-04-15
CN1034171C (zh) 1997-03-05
PL293531A1 (en) 1992-08-24
JPH04346980A (ja) 1992-12-02
HU211886A9 (en) 1995-12-28
NZ241659A (en) 1993-03-26
FI920720A7 (fi) 1992-08-21
EP0500409A1 (fr) 1992-08-26
ZA921203B (en) 1992-11-25
FR2672892B1 (fr) 1994-01-14
DE69209113D1 (de) 1996-04-25
CS49092A3 (en) 1992-09-16
IL101014A0 (en) 1992-11-15
FI920720A0 (fi) 1992-02-19
NO920648L (no) 1992-08-21
HUT60477A (en) 1992-09-28
GR3019404T3 (en) 1996-06-30
AU650319B2 (en) 1994-06-16
AU1105992A (en) 1992-08-27

Similar Documents

Publication Publication Date Title
ES2062395T3 (es) Nuevos compuestos de bencimidazol y su uso.
ES2118095T3 (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ES2100907T3 (es) Bencimidazoles, medicamentos que contienen estos compuestos y proced imiento para su preparacion.
ES2194314T3 (es) Derivados de benzopirano sustituidos para el tratamiento de inflamaciones.
CO4960662A1 (es) Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
MX9203122A (es) Compuestos analogos de distamicina a y composiciones farmaceuticas que los contienen.
BR9914451A (pt) Composto de oxazol, processo para sua preparação, composição farmacêutica compreendendo dito composto, uso da composição e métodos de tratamento
CO5251440A1 (es) Derivados de heterociclil-fenil-oxazolidin-tiofencarboxamida, su procedimiento de obtencion y medicamentos que los contienen
ES2168953A1 (es) Derivados de oxima y su uso como acidos latentes
AR027437A1 (es) Derivados de purina
ES2158284T3 (es) Metil-fenil-oxazolidinonas quirales.
CO5011045A1 (es) Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos
DE69005164D1 (de) Acryloylsubstituierte Pyrrol-Derivate.
FI870347A0 (fi) Nya dihydrobensofuran- och kromankarboxiamidderivat, foerfarande foer deras framstaellning och deras anvaendning som neuroleptiska medel.
ES2177058T3 (es) Compuestos eter piperidinilaminometil trifluorometil ciclicos como antagonistas de la sustancia p.
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
BR9913405A (pt) Composto heterocìclico que contenha oxigênio, e, inibidor de fosfodiesterase (pde) iv.
CO4990933A1 (es) Derivados de indazol triciclicos, su preparacion y su apli- cacion en terapeutica
ES2157315T3 (es) Derivados de 2-arilalquenil-azacicloalcanos ligandos a los receptores sigma, su procedimiento de preparacion y su aplicacion en terapeutica.
ES2191109T3 (es) Inhibidores de proteasas de guanidino.
ES2133686T3 (es) Nuevos derivados de benzopirano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2152379T3 (es) Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos.
ES2143675T3 (es) Bencenosulfonil-ureas-tioureas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
AR026350A1 (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa vii
CO5080802A1 (es) Nuevos compuestos heterociclicos inhibidores de la fosfodiesteresa iv y su formulacion y uso como productos farmaceuticos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 500409

Country of ref document: ES